|
1111
|
|
|
Caspase 1 |
ICE, IL1BC, P45 |
Amyotrophic lateral sclerosis, Hyperhomocysteinemia, Hypersensitivity, Diabetes mellitus, type 2, Kidney disease, Liver cirrhosis, Motor neuron disease, Multiple sclerosis, Obesity, Status epilepticus |
|
1112
|
|
|
Cell division cycle associated 3 |
GRCC8, TOME-1, TOME1 |
|
|
1113
|
|
|
Caspase 2 |
CASP-2, ICH1, MRT80, NEDD-2, NEDD2, PPP1R57 |
|
|
1114
|
|
|
Carbohydrate sulfotransferase 9 |
GALNAC4ST-2, GalNAc4ST2 |
|
|
1115
|
|
|
Component of oligomeric golgi complex 3 |
CDG2BB, SEC34 |
|
|
1116
|
|
|
Caspase 3 |
CPP32, CPP32B, SCA-1 |
Alzheimer disease, Brain ischemia, Calcinosis, Cerebral hemorrhage, Ulcerative colitis, Cryptorchidism, Experimental diabetes, Diabetes mellitus type 2, Diabetic angiopathies, Diabetic neuropathy, Diabetic peripheral angiopathy, Diabetic retinopathy, Edema, Heart valve disease, Heart valve prolapse, Hepatitis, Kawasaki disease, Myocardial infarction, Nervous system disease, Parkinson disease, Retinal detachment, Schizophrenia, Sepsis, Status epilepticusView all (9 more) |
|
1117
|
|
|
CCM2 scaffold protein |
C7orf22, OSM, PP10187 |
Cavernous malformations of cns, Cerebral cavernous malformation, Colorectal cancer, Coronary artery disease, Vascular dementia, Developmental venous anomaly, Cerebral cavernous malformations, Myocardial infarction, Diabetes mellitus, type 2, Vasculitis |
|
1118
|
|
|
Chromosome 19 open reading frame 12 |
MPAN, NBIA3, NBIA4, SPG43 |
Spastic paraplegia, Breast cancer, Estrogen-receptor negative breast cancer, Global developmental delay, Hallervorden spatz syndrome, Intellectual developmental disorder, Urinary system cancer, Metabolic syndrome, Neurodegeneration with brain iron accumulation, Ovarian neoplasm, Ovarian serous carcinoma, Spastic ataxia, Hereditary spastic paraplegia, Diabetes mellitus, type 2, Urinary bladder cancer |
|
1119
|
|
|
Chromosome 11 open reading frame 68 |
BLES03, P5326 |
|
|
1120
|
|
|
Coiled-coil domain containing 3 |
- |
|